Doctor profile · Federal record
Dr. David Avram, MD
Specialist (CMS: Dermatology) · Brooklyn, NY
- NPI 1972598100
- MIPS 97.2 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
115 Remsen St
Brooklyn, NY 112014212
(718) 852-4646
fax (718) 624-5972
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- November 10, 2008
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- New York #224352
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972598100. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,765
Distinct HCPCS
10
Medicare allowed
$540,454
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,698 | 1,022 | $101 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,244 | 238 | $8 | |
11102 |
Biopsy of related skin growth, first growth | 632 | 534 | $112 | |
17000 |
Destruction of precancer skin growth, 1 growth | 528 | 376 | $63 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 246 | 188 | $64 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 227 | 227 | $128 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 215 | 51 | $1 | |
17110 |
Destruction of skin growth, 1-14 growths | 208 | 168 | $128 | |
11103 |
Biopsy of related skin growth, each additional growth | 134 | 115 | $57 | |
11901 |
Injection into skin growth, more than 7 growths | 88 | 19 | $75 |
In context: peer comparison
Among 50 peers in Brooklyn Specialist, average services per provider: 234. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$5,407
Transactions
75
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, INC. | 16 | $4,024.56 | |
| Janssen Biotech, INC. | 12 | $368.67 | |
| Abbvie INC. | 10 | $224.40 | |
| Ucb, INC. | 9 | $158.08 | |
| Pfizer INC. | 7 | $147.58 | |
| Genzyme Corporation | 4 | $123.92 | |
| Amgen INC. | 3 | $73.25 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 3 | $72.50 | |
| Arcutis Biotherapeutics, INC. | 3 | $66.78 | |
| Lilly USA, LLC | 3 | $65.58 | |
| Galderma Laboratories, L.P. | 2 | $34.69 | |
| Solta Medical, A Division of Bausch Health US, LLC | 1 | $19.73 | |
| Regeneron Healthcare Solutions, INC. | 1 | $18.75 | |
| Mayne Pharma Commercial LLC | 1 | $8.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,039
Patients
708
Total drug cost
$30,772
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 195 | 155 | $1,884 |
| Ketoconazole | Generic | 162 | 107 | $3,376 |
| Clobetasol Propionate | Generic | 82 | 58 | $5,998 |
| Mupirocin | Generic | 78 | 62 | $689 |
| Nystatin | Generic | 73 | 34 | $751 |
| Fluocinonide | Generic | 69 | 48 | $3,691 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 66 | 50 | $963 |
| Clindamycin Phosphate | Generic | 53 | 38 | $3,330 |
| Minoxidil | Generic | 52 | 11 | $499 |
| Ciclopirox | Generic | 46 | 26 | $1,414 |
Frequently asked questions
What is Dr. David Avram's medical specialty?
Dr. David Avram practices Specialist in Brooklyn, NY.
Where does Dr. David Avram practice?
Dr. David Avram practices at 115 Remsen St, Brooklyn, NY 112014212. Office phone: 7188524646.
What is Dr. David Avram's NPI?
Dr. David Avram's National Provider Identifier (NPI) is 1972598100, issued by NPPES.
Does Dr. David Avram accept Medicare assignment?
Dr. David Avram does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. David Avram commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.